Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Inventory (2016 - 2025)

Vanda Pharmaceuticals' Change in Inventory history spans 13 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 1096.26% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $3.5 million, up 11851.72%, while the annual FY2025 figure was $3.5 million, 11851.72% up from the prior year.
  • Change in Inventory for Q4 2025 was $1.3 million at Vanda Pharmaceuticals, up from -$32000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.8 million in Q1 2025 and bottomed at -$263000.0 in Q2 2024.
  • The 5-year median for Change in Inventory is $385500.0 (2022), against an average of $548900.0.
  • The largest annual shift saw Change in Inventory tumbled 133.75% in 2023 before it soared 6479.31% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $77000.0 in 2021, then surged by 1367.53% to $1.1 million in 2022, then crashed by 62.21% to $427000.0 in 2023, then plummeted by 74.94% to $107000.0 in 2024, then soared by 1096.26% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Change in Inventory are $1.3 million (Q4 2025), -$32000.0 (Q3 2025), and $368000.0 (Q2 2025).